Frontier Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $611K | Hold |
3,917
| – | – | 0.04% | 137 |
|
|
2020
Q1 | $565K | Hold |
3,917
| – | – | 0.04% | 128 |
|
|
2019
Q4 | $801K | Hold |
3,917
| – | – | 0.05% | 134 |
|
|
2019
Q3 | $314K | Hold |
3,917
| – | – | 0.02% | 194 |
|
|
2019
Q2 | $370K | Hold |
3,917
| – | – | 0.02% | 167 |
|
|
2019
Q1 | $335K | Hold |
3,917
| – | – | 0.02% | 183 |
|
|
2018
Q4 | $220K | Hold |
3,917
| – | – | 0.02% | 203 |
|
|
2018
Q3 | $320K | Buy |
+3,917
| New | +$320K | 0.02% | 187 |
|